This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
Bavarian Nordic’s Jynneos mpox vaccine for adolescents aged 12 to 17 was approved on Oct. 8.
A virology expert explains symptoms and ways to prevent infection and spread.
Victorian Chief Health Officer Clare Looker recommended 2 doses of the vaccine.
